| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/18/2008 | CA2175697C Diagnosis of mental disorders |
| 03/18/2008 | CA2167980C Cgrp antagonist used in a cosmetic composition; pharmaceutical or dermatologic composition produced |
| 03/18/2008 | CA2089735C Ryegrass pollen allergen |
| 03/18/2008 | CA2015060C Novel antibody delivery system for biological response modifiers |
| 03/13/2008 | WO2008031098A1 Binary amino acid libraries for fibronectin type iii polypeptide monobodies |
| 03/13/2008 | WO2008031061A2 Anti-activin a antibodies and uses thereof |
| 03/13/2008 | WO2008030706A2 Anti-myostatin antibodies |
| 03/13/2008 | WO2008030564A2 Aglycosylated antibodies and methods of making and using those antibodies |
| 03/13/2008 | WO2008030543A2 Tyrosine, serine and threonine phosphorylation sites |
| 03/13/2008 | WO2008030251A1 Deglycosylated anti-amyloid beta antibodies |
| 03/13/2008 | WO2008030122A1 Biomarkers |
| 03/13/2008 | WO2008029807A1 Novel polypeptide having cytotoxicity against cancer, method for screening for the polypeptide, and use of the polypeptide |
| 03/13/2008 | WO2008028946A2 Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof |
| 03/13/2008 | WO2008028501A1 Methods for blocking the interaction between nkp80 and its ligand aicl |
| 03/13/2008 | WO2008028405A1 Neukinase, a downstream protein of neuregulin |
| 03/13/2008 | WO2008013934A8 Tyrosine phosphorylation sites |
| 03/13/2008 | WO2008006554A8 Glyco-engineered antibodies |
| 03/13/2008 | WO2008005455A3 Peptide antibody depletion and its application to mass spectrometry sample preparation |
| 03/13/2008 | WO2007143090A3 Hepatocyte growth factor (hgf) binding proteins |
| 03/13/2008 | WO2007130697A3 Anti-ephb4 antibodies and methods using same |
| 03/13/2008 | WO2007128553A9 Mig12 |
| 03/13/2008 | WO2007127476A3 Monoclonal antibodies specific for pancreatic endocrine, exocrine or ductal cell |
| 03/13/2008 | WO2007117763A3 Methods and compositions for targeting relt |
| 03/13/2008 | WO2007116360A3 Antibodies that bind human protein tyrosine phosphatase beta (hptpbeta) and uses thereof |
| 03/13/2008 | WO2007111714A3 Il-21 antagonists |
| 03/13/2008 | WO2007109376A3 Anti-tumor cell antigen antibody therapeutics |
| 03/13/2008 | WO2007106769A3 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 03/13/2008 | WO2007102736A3 Interfering in activation of an immune cell by influencing interaction of lair and collagen. |
| 03/13/2008 | WO2007064917A3 Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins |
| 03/13/2008 | WO2007002543A8 Antibody formulations having optimized aggregation and fragmentation profiles |
| 03/13/2008 | WO2005010153A3 Antibodies and uses thereof |
| 03/13/2008 | US20080066200 Transgenic plant which serves as bioreactor for expression of humanized glycoproteins with reduced fucose and xylose residues |
| 03/13/2008 | US20080066195 Taste Receptors of the T1r Family Form Domestic Cat |
| 03/13/2008 | US20080064858 Binding partners for the thyrotropin receptor and uses thereof |
| 03/13/2008 | US20080064857 Immunoglobulin for use in diagnosis, prevention and treatment of metabolic disorders of pancreas |
| 03/13/2008 | US20080064854 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof |
| 03/13/2008 | US20080064764 Isolated nucleic acids; antibody for selective binding; biodrug treating osteoporosis, osteoblast, bone disorders, osteocalcin mediated disorder |
| 03/13/2008 | US20080064660 Modulation of Inflammation Related to Columnar Epithelia |
| 03/13/2008 | US20080064631 T-cell receptors for use in diagnosis and therapy of cancers and autoimmune disease |
| 03/13/2008 | US20080064630 Prolonged circulation time; combined with such as human growth hormone or fragments; nucleic acid constructs, vectors, host cells; culturing and harvesting |
| 03/13/2008 | US20080064104 Antagonists and agonists of ldcam and methods of use |
| 03/13/2008 | US20080064103 Identifying regulatory compounds which dissociate/destsbilize receptor/ligand binding activity; for use in controlled immune suppression |
| 03/13/2008 | US20080064097 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 03/13/2008 | US20080064096 Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
| 03/13/2008 | US20080064094 Polynucleotides encoding two novel human G-protein coupled receptors, HGPRBMY28 and HGPRBMY29, and splice variants thereof |
| 03/13/2008 | US20080064079 Mutant trypsin; protein engineering and sequencing |
| 03/13/2008 | US20080064060 Major histocompatibility complex proteins for use in tissue targeted therapy of tumor antigens; diagnosing organ transplant rejection |
| 03/13/2008 | US20080063717 Anti-NCR antibody or immunoreactive fragments and an interleukin, cytokine; administered together or separately; tablet, powder, pastes, patches, granules, microgranules, nanoparticules, colloid solution, aqueous solution, injectable solutions, sprays, or liposomes; subcutaneous injection |
| 03/13/2008 | US20080063674 Cosmetic Composition Containing Protein Hydrolysates |
| 03/13/2008 | US20080063657 antigen and flagellin which lacks a hinge region; antigen and flagellin are components of a fusion protein; pathogen-associated molecular pattern (PAMP) and a flavivirus; West Nile, Langat, Kunjin, Murray Valley encephalitis, Japanese encephalitis, Tick-borne encephalitis, Yellow fever viral proteins |
| 03/13/2008 | US20080063651 therapeutic protein comprising a tenth domain of fibronectin type III; protein scaffold; antibody design; scaffold derived from a fibronectin type III (Fn3) or Fn3-like domain, function like natural or engineered antibodies; antibody mimics designed for optimal folding, stability, and solubility |
| 03/13/2008 | US20080063649 pretreatment step involving a highly specific and high affinity neutralizing antibody |
| 03/13/2008 | US20080063647 Antibodies against protective antigen and methods of use for passive immunization and treatment of anthrax |
| 03/13/2008 | US20080063646 variable heavy chain amino acid sequence of SEQ ID NO. 50 and a variable light chain amino acid sequence of SEQ ID NO. 48, designated herein as HuAIP12 |
| 03/13/2008 | US20080063644 immunohistochemistry; skin thickening caused by ultraviolet treated by using the antibody; inhibit production of IFN-.gamma; promoting keratinocyte differentiation induction and suppressing epidermal thickening, skin cancer; inhibiting growth of keratinocytes; promotes hair growth; hyperplasia |
| 03/13/2008 | US20080063643 HLA-binding motif in its sequence; recognized by an HLA-A2- or HLA-A24-restricted cytotoxic T cell; nucleotide; antibody; vector; diagnosid and prognosis of hepatitis C virus infection |
| 03/13/2008 | US20080063641 Comprise a single antigen binding arm and an Fc region; exhibits enhanced stability in vivo compared to a Fab antibody fragment |
| 03/13/2008 | US20080063638 Mitotic kinesin-like protein-1, MKLP1, and uses therof priority |
| 03/13/2008 | US20080063636 polypeptides having deletions in the amino acid sequence, useful as antigens for improving vaccine therapy; treatment of Alzheimer's disease |
| 03/13/2008 | US20080063635 Stabilized Human Igg4 Antibodies |
| 03/13/2008 | US20080063634 genetic engineered antibody or antigen binding segment that is capable of binding to interleukins and altering the conformation structure, used for treating diseases involving immune and inflammatory responses |
| 03/13/2008 | US20080063633 Fusion proteins comprising single chain FV fragment of an antibody, and transport proteins, used for treatment of skin cancer |
| 03/13/2008 | US20080063630 polynucleotides that code for polypeptides having activity for targeting heterogeneous polypeptides to the surfaces of cytoplasmic membranes, useful for analysis of proteind, delivery of cells expressing the polypeptide to a target site in vivo, preparation of an antibodies and vaccines, and gene therapy |
| 03/13/2008 | US20080063600 use of deactivated lymphocytes, antibodies, drug mixtures and adjuvants, for the treatment or prevention of Cruetzfield-Jacobs disease in humans or animals; immunology; bioassays |
| 03/13/2008 | US20080063598 chimeric antibodies, fragments, polypeptides and derivatives that preferentially bind tumor associated antigens (AF-20), useful in the treatment and diagnosis of cancers |
| 03/13/2008 | CA2698597A1 Monitoring cancer stem cells |
| 03/13/2008 | CA2663388A1 Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof |
| 03/13/2008 | CA2663042A1 Serum albumin binding proteins with long half-lives |
| 03/13/2008 | CA2662480A1 Methods and compositions for the treatment of antibody mediated neuropathies |
| 03/13/2008 | CA2662350A1 Antibodies to bone morphogenic proteins and receptors therefor and methods for their use |
| 03/13/2008 | CA2662340A1 Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 03/13/2008 | CA2662226A1 Fully human high yield production system for improved antibodies and proteins |
| 03/13/2008 | CA2661923A1 Methods for blocking the interaction between nkp80 and its ligand aicl |
| 03/13/2008 | CA2661878A1 Anti-activin a antibodies and uses thereof |
| 03/13/2008 | CA2661836A1 Anti-myostatin antibodies |
| 03/13/2008 | CA2661645A1 Arginine wash in protein purification using affinity chromatography |
| 03/13/2008 | CA2661308A1 Neukinase, a downstream protein of neuregulin |
| 03/13/2008 | CA2654283A1 Methods of diagnosing and treating complications of pregnancy |
| 03/12/2008 | EP1897950A2 Human GIL-19/AE289 proteins and polynucleotides encoding same |
| 03/12/2008 | EP1897949A2 Human interleukin-B50. Therapeutic uses |
| 03/12/2008 | EP1897948A1 Mammalian transforming growth factor beta 9 |
| 03/12/2008 | EP1897947A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897946A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897945A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897944A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897943A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897891A1 Diagnosis of hereditary spastic paraplegias (HSP) by detection of a mutation in the KIAA1840 gene or protein |
| 03/12/2008 | EP1897890A1 Affinity purification of polypeptide on protein A matrix |
| 03/12/2008 | EP1897556A1 Prevention and treatment of hypergastrinemia |
| 03/12/2008 | EP1897548A1 T cell regulation |
| 03/12/2008 | EP1897441A1 TGF-alpha polypeptides, functional fragments and methods of use therefor |
| 03/12/2008 | EP1896855A2 Biomarkers for breast cancer |
| 03/12/2008 | EP1896849A2 Antibodies against histone modifications for clinical diagnosis and prognosis of cancer |
| 03/12/2008 | EP1896589A2 Novel genes and proteins of brachyspira pilosicoli and use of same for diagnosis and therapy |
| 03/12/2008 | EP1896582A1 Human monoclonal antibodies to programmed death 1(pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics |
| 03/12/2008 | EP1896507A2 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
| 03/12/2008 | EP1896506A2 Methods of purifying anti a beta antibodies |
| 03/12/2008 | EP1896504A2 Methods of purifying fc region containing proteins |
| 03/12/2008 | EP1896503A2 Igg1 antibodies with mutated fc portion for increased binding to fcrn receptor and uses tehereof |
| 03/12/2008 | EP1896073A2 Anti-il-23 antibodies, compositions, methods and uses |